TY  - GEN
AU  - Dearnaley,David P
AU  - Sydes,Matthew R
AU  - Mason,Malcolm D
AU  - Stott,Mark
AU  - Powell,Christopher S
AU  - Robinson,Anne C R
AU  - Thompson,Peter M
AU  - Moffat,Leslie E
AU  - Naylor,Sharon L
AU  - Parmar,Mahesh K B
TI  - A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial)
SN  - 1460-2105
PY  - 2003///0917
KW  - Administration, Oral
KW  - Aged
KW  - Analgesics, Non-Narcotic
KW  - administration & dosage
KW  - Androgen Antagonists
KW  - Antineoplastic Agents, Hormonal
KW  - Bone Neoplasms
KW  - complications
KW  - Clodronic Acid
KW  - Digestive System
KW  - drug effects
KW  - Diphosphonates
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Imidazoles
KW  - Male
KW  - Middle Aged
KW  - Odds Ratio
KW  - Pain
KW  - etiology
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Research Design
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - United Kingdom
KW  - Zoledronic Acid
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/jnci/djg038
ER  -